Sale!

KCNA5 Gene Atrial Fibrillation Type 7 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “KCNA5 Gene Atrial Fibrillation Type 7 Genetic Test” is a specialized diagnostic procedure aimed at detecting mutations in the KCNA5 gene, which have been associated with Atrial Fibrillation Type 7. Atrial fibrillation (AF) is a common cardiac rhythm disorder characterized by rapid and irregular beating of the atria, the two upper chambers of the heart. Type 7 of this condition is genetically linked, specifically to mutations in the KCNA5 gene, which encodes for a potassium channel involved in the electrical activity of the heart. Identifying mutations in this gene can help in understanding the genetic basis of atrial fibrillation in affected individuals, potentially leading to personalized treatment plans and management strategies.

The test is offered at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis, including the use of sophisticated technology to accurately identify genetic variations associated with the condition. This test is particularly valuable for individuals with a family history of atrial fibrillation or those who have been diagnosed with the condition without an identifiable cause, as it provides critical insights into the genetic factors influencing the disorder.

Description

KCNA5 Gene Atrial fibrillation type 7 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KCNA5 Gene Atrial fibrillation type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNA5 Gene Atrial fibrillation type 7 NGS Genetic DNA Test gene KCNA5

Test Details: The KCNA5 gene is a gene that codes for a potassium channel protein involved in the regulation of electrical signaling in the heart. Mutations in this gene have been associated with an increased risk of developing atrial fibrillation, a common type of irregular heart rhythm. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of atrial fibrillation type 7, NGS genetic testing can be used to identify any mutations or variations in the KCNA5 gene that may be contributing to the development of the condition. By analyzing the DNA sequence of the KCNA5 gene, NGS genetic testing can provide information about the specific genetic variants present in an individual’s genome. This can help in determining the individual’s risk for developing atrial fibrillation and may guide treatment decisions or interventions to manage the condition. It is important to note that genetic testing alone may not be sufficient to diagnose atrial fibrillation or predict its development. Other clinical and diagnostic tests may be necessary to confirm the presence of the condition. Genetic testing should be performed and interpreted by a qualified healthcare professional who specializes in genetics.

Test Name	KCNA5 Gene Atrial fibrillation type 7 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for KCNA5 Gene Atrial fibrillation type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNA5 Gene Atrial fibrillation type 7 NGS Genetic DNA Test gene KCNA5
Test Details	The KCNA5 gene is a gene that codes for a potassium channel protein involved in the regulation of electrical signaling in the heart. Mutations in this gene have been associated with an increased risk of developing atrial fibrillation, a common type of irregular heart rhythm. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of atrial fibrillation type 7, NGS genetic testing can be used to identify any mutations or variations in the KCNA5 gene that may be contributing to the development of the condition. By analyzing the DNA sequence of the KCNA5 gene, NGS genetic testing can provide information about the specific genetic variants present in an individual’s genome. This can help in determining the individual’s risk for developing atrial fibrillation and may guide treatment decisions or interventions to manage the condition. It is important to note that genetic testing alone may not be sufficient to diagnose atrial fibrillation or predict its development. Other clinical and diagnostic tests may be necessary to confirm the presence of the condition. Genetic testing should be performed and interpreted by a qualified healthcare professional who specializes in genetics.